Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
83,777,518
-
Share change
-
-3,148,323
-
Total reported value
-
$1,316,226,289
-
Put/Call ratio
-
21%
-
Price per share
-
$15.71
-
Number of holders
-
302
-
Value change
-
-$49,940,581
-
Number of buys
-
121
-
Number of sells
-
121
Institutional Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q2 2023
As of 30 Jun 2023,
TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) was held by
302 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
83,777,518 shares.
The largest 10 holders included
Capital Research Global Investors, MORGAN STANLEY, GOLDMAN SACHS GROUP INC, Mondrian Investment Partners LTD, MACQUARIE GROUP LTD, RENAISSANCE TECHNOLOGIES LLC, MILLENNIUM MANAGEMENT LLC, Clal Insurance Enterprises Holdings Ltd, FMR LLC, and BlackRock Inc..
This page lists
308
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.